Kalytera Announces Next Share Issuance for Services under Payments Agreement with Salzman Group
November 12, 2018 13:35 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
Kalytera Announces Next Share Issuance under Payments Agreements with Salzman Group
September 28, 2018 07:30 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
Kalytera Announces Grant of Stock Options to Directors and Employees
September 24, 2018 20:07 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has...
Kalytera Confirms No Material Change in Operations
September 13, 2018 15:11 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Sept. 13, 2018 (GLOBE NEWSWIRE) -- At the request of IIROC, Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") wishes...
Kalytera Announces Next Payment of Invoices in Shares under Payments Agreements with Salzman Group
September 07, 2018 17:34 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
Kalytera Provides Update on Arrangement with Former Shareholders of Talent Biotechs
August 24, 2018 08:27 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today provided an update on the...
Kalytera Announces Further Payments in Shares under Payments Agreements with Salzman Group
August 17, 2018 17:09 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
Kalytera Therapeutics, Inc. Announces Exercise of Over-Allotment Option
August 16, 2018 11:05 ET
|
Kalytera Therapeutics, Inc.
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. SAN FRANSISCO...
Kalytera Therapeutics, Inc. Announces Closing of Public Offering
August 08, 2018 12:59 ET
|
Kalytera Therapeutics, Inc.
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. SAN FRANSISCO...
Kalytera Therapeutics Announces Adjournment of 2018 Annual and Special Meeting
July 27, 2018 17:08 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, July 27, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the “Company”, or “Kalytera”) (TSXV:KALY) (OTCQB:KALTF) announced today that the annual and special...